Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H46O3 |
Molecular Weight | 430.663 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C)[C@H](C)CCCCC(C)(C)O
InChI
InChIKey=WKTIGYIYJKESCJ-JJWMBMNSSA-N
InChI=1S/C28H46O3/c1-19(9-6-7-15-27(3,4)31)24-13-14-25-21(10-8-16-28(24,25)5)11-12-22-17-23(29)18-26(30)20(22)2/h11-12,19,23-26,29-31H,2,6-10,13-18H2,1,3-5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,28-/m1/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P11473 Gene ID: 7421.0 Gene Symbol: VDR Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3033654 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
103656-40-2
Created by
admin on Sat Dec 16 01:39:58 GMT 2023 , Edited by admin on Sat Dec 16 01:39:58 GMT 2023
|
PRIMARY | |||
|
F35KTH803S
Created by
admin on Sat Dec 16 01:39:58 GMT 2023 , Edited by admin on Sat Dec 16 01:39:58 GMT 2023
|
PRIMARY | |||
|
F35KTH803S
Created by
admin on Sat Dec 16 01:39:58 GMT 2023 , Edited by admin on Sat Dec 16 01:39:58 GMT 2023
|
PRIMARY | |||
|
1423458
Created by
admin on Sat Dec 16 01:39:58 GMT 2023 , Edited by admin on Sat Dec 16 01:39:58 GMT 2023
|
PRIMARY | RxNorm | ||
|
9547481
Created by
admin on Sat Dec 16 01:39:58 GMT 2023 , Edited by admin on Sat Dec 16 01:39:58 GMT 2023
|
PRIMARY | |||
|
DB15557
Created by
admin on Sat Dec 16 01:39:58 GMT 2023 , Edited by admin on Sat Dec 16 01:39:58 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD